Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,998 | 161 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $453.56 | 26 | $0 (2024) |
| ABBVIE INC. | $447.46 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $259.76 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $225.58 | 16 | $0 (2024) |
| Lilly USA, LLC | $200.56 | 7 | $0 (2023) |
| Astellas Pharma US Inc | $146.79 | 7 | $0 (2024) |
| PFIZER INC. | $120.42 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.24 | 6 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $100.07 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $91.23 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $869.00 | 42 | ABBVIE INC. ($166.89) |
| 2023 | $846.55 | 43 | Novo Nordisk Inc ($171.49) |
| 2022 | $598.61 | 33 | ABBVIE INC. ($136.12) |
| 2021 | $67.74 | 4 | Novo Nordisk Inc ($18.83) |
| 2019 | $181.83 | 12 | AstraZeneca Pharmaceuticals LP ($60.45) |
| 2018 | $213.34 | 13 | AstraZeneca Pharmaceuticals LP ($66.25) |
| 2017 | $221.02 | 14 | Merck Sharp & Dohme Corporation ($88.19) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Biological | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Diabetes Care | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $44.72 | General |
| Category: INSTRUMENTS | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/23/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: VACCINE | ||||||
| 08/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: ADHD | ||||||
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Endocrinology | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Obesity | ||||||
| 06/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: PSYCHIATRY | ||||||
| 05/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/20/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Central Nervous System | ||||||
| 04/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.83 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,648 | 1,912 | $202,745 | $78,312 |
| 2022 | 20 | 1,316 | 1,522 | $151,141 | $74,952 |
| 2021 | 15 | 745 | 870 | $128,435 | $43,580 |
| 2020 | 13 | 1,383 | 1,612 | $223,827 | $60,789 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 292 | 468 | $78,783 | $24,109 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 336 | 406 | $48,302 | $18,393 | 38.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $8,910 | $7,345 | 82.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 73 | 75 | $6,355 | $5,388 | 84.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 167 | 167 | $4,175 | $3,220 | 77.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 43 | 43 | $9,460 | $3,142 | 33.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 70 | 72 | $4,380 | $2,879 | 65.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 78 | $3,948 | $2,500 | 63.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 107 | 107 | $19,260 | $2,309 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,660 | $2,283 | 49.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $2,520 | $2,227 | 88.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 116 | 116 | $2,900 | $2,198 | 75.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $936.00 | $833.30 | 89.0% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 163 | 164 | $3,280 | $315.53 | 9.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 30 | $1,950 | $287.09 | 14.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 19 | $475.00 | $275.74 | 58.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 25 | $375.00 | $238.00 | 63.5% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 15 | 16 | $800.00 | $196.20 | 24.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 14 | 14 | $826.00 | $120.50 | 14.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 23 | 25 | $450.00 | $52.80 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 411 | 547 | $58,529 | $27,112 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 281 | $43,836 | $17,638 | 40.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 47 | 47 | $10,340 | $5,888 | 56.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 48 | 48 | $8,640 | $4,677 | 54.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $3,410 | $3,061 | 89.8% |
About Dr. Sony John, MD
Dr. Sony John, MD is a Family Medicine healthcare provider based in Kennett Square, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1316109119.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sony John, MD has received a total of $2,998 in payments from pharmaceutical and medical device companies, with $869.00 received in 2024. These payments were reported across 161 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,998).
As a Medicare-enrolled provider, John has provided services to 5,092 Medicare beneficiaries, totaling 5,916 services with total Medicare billing of $257,634. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kennett Square, PA
- Active Since 07/02/2008
- Last Updated 05/12/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316109119
Products in Payments
- VRAYLAR (Drug) $186.95
- Ozempic (Drug) $159.74
- JARDIANCE (Drug) $129.27
- MOUNJARO (Drug) $123.73
- JANUVIA (Drug) $116.94
- Veozah (Drug) $111.98
- QULIPTA (Drug) $108.58
- JORNAY PM (Drug) $100.07
- UBRELVY (Drug) $95.94
- ELIQUIS (Drug) $88.56
- FARXIGA (Drug) $80.82
- Rybelsus (Drug) $75.68
- Victoza (Drug) $67.49
- Wegovy (Drug) $66.17
- TRULICITY (Drug) $62.80
- Cologuard Collection Kit (Device) $62.05
- BEVESPI AEROSPHERE (Drug) $56.20
- REXULTI (Drug) $55.46
- FASENRA (Biological) $54.78
- SHINGRIX (Biological) $52.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kennett Square
Matthew Pagano, D.o, D.O
Family Medicine — Payments: $2,180
Elaine Kirchdoerfer, Md, MD
Family Medicine — Payments: $316.55
Pedro Solanet, Md, MD
Family Medicine — Payments: $245.96
Steven Ginsburg, Do, DO
Family Medicine — Payments: $188.83
Michael Welsh, Do, DO
Family Medicine — Payments: $172.85
Cheryl Hlavac, Md, MD
Family Medicine — Payments: $124.68